Dr Renuka Shanmugalingam awarded at APCH2019
Dr Renuka Shanmugalingam was awarded the Student Prize at the 15th Asian-Pacific Congress of Hypertension 2019 for her work investigating the effects of aspirin on placental growth factor and the development of preeclampsia.
Assoc Prof Simone Schoenwaelder awarded Brain Foundation Research Gift
Assoc Prof Simone Schoenwaelder was awarded a Brain Foundation Research Gift for her work ‘Identification of New Approaches for the Treatment of Stroke’. These Gifts are awarded to applicants on the scientific quality and significance and/or innovation of their research.
Face reveals dark secrets of the heart
HRI has worked on new camera technology that can detect deadly heart problems by scanning patients' faces in a GP waiting room.
HRI’s Dr Marc Ellis awarded the RCPA Kanematsu Research Award 2019
HRI’s Dr Marc Ellis has received the RCPA Kanematsu Research Award 2019 to support his research into how platelets become activated by turbulent blood flow, and why this process is increased in diabetes.
Illuminate 2019 – Celebrating 30 years of discovery at HRI
The Heart Research Institute’s annual Awards for Excellence dinner, Illuminate, celebrated 30 years of discovery at HRI this year.
Dr Ju awarded Future Leader Fellowship and Paul Korner Innovation Award
HRI’s Dr Lining (Arnold) Ju has been awarded a Heart Foundation Future Leader Fellowship as well as the Heart Foundation Paul Korner Innovation Award.
HRI’s Dr Renuka Shanmugalingam awarded at SOMANZ
HRI’s Dr Renuka Shanmugalingam recently received the SOMANZ Andrew Phippard Memorial Award for best scientific research oral presentation.
HRI raises awareness on World Thrombosis Day
To celebrate World Thrombosis Day, HRI’s Thrombosis and Haematology Research Groups did their part to raise awareness of thrombosis – a leading factor in heart attacks and stroke.
Dr Anna Waterhouse presents keynote lecture at inaugural Nature Conference
Dr Anna Waterhouse delivered the prestigious keynote lecture ‘Biomimicry in blood-contacting medical devices’, presenting the problem of thrombosis, fibrosis and microbe biofouling with blood-contacting medical devices, highlighting that relying on drugs to solve medical device problems results in increased risks of adverse events for patients.